baber/WOPTO huggingface dataset:
Patent AU-2008202685-B2 (AU)
Title: Medical monitor user interface
Inventor: FASCIANO ROBERT
IPC: A61B5/00
Filed: 2008-06-18
Granted: 2014-09-04
Abstract: Methods and devices useful for monitoring a patient and for monitoring and displaying the value of a physiological parameter are disclosed. In one embodiment, a user interface for a medical monitoring device is provided. The user interface can 5 have a monitoring screen with a current value screen and a trend screen. The current value screen can displaying a graphical representation of a value of a physiological parameter over time, e.g., over a current time period, and the trend screen can display a graphical representation of a mean value of the physiological parameter over time, e.g., over a historical time period. The time periods can be adjustable. In some 10 embodiments, an out-of-limit condition for the physiological parameter can be indicated with shading. For example, the current value screen can display shading between a trendline representing the value of the physiological parameter and a threshold line, which sets the alarm threshold. The historical value screen can display shading between a trendline representing the value of the physiological 15 parameter and another threshold line. In yet other embodiments, the user interface can provide an event marking screen. The event marking screen can provide the ability to mark events, e.g., delivery of a drug to the patient, adjustment of a sensor, and so on, on a historical trend screen that displays a value of the physiological parameter over time. Such event marking can enable a caregiver to correlate events 20 to a change in a patient's condition as manifested by the physiological parameter. 17/06/08,kn 17329 specificaion,20 FIG. 1 (Prior Art)
Patent AU-2008215840-B2 (AU)
Title: Control of transport properties to and from nanoparticle surfaces
Inventor: ANDERSON DARREN
IPC: C07K1/00
Filed: 2008-02-15
Granted: 2013-06-27
Abstract: Methods of producing stabilized composite nanoparticles comprising a nanoparticle and a multiple polyelectrolyte stabilizing moiety layer, a method of producing a multilayer stabilized composite nanoparticle, and such nanoparticles.
Patent AU-2008219317-B2 (AU)
Title: Aryl carboxylic acid cyclohexyl amide derivatives
Inventor: WOLFGANG MILTZ
IPC: A61P31/18
Filed: 2008-02-18
Granted: 2011-09-08
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt or prodrug ester thereof: (I) wherein the variants R and X are defined in the specification.
Patent AU-2008258185-B2 (AU)
Title: Prostate stem cell antigen (PSCA) variants and subsequences thereof
Inventor: CHALLITA-EID PIA M
IPC: C12N5/095
Filed: 2008-12-17
Granted: 2011-12-08
Abstract: #BSTRACT PSCA and its encoded protein, and variants thereof, are described wherein PSCA exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table 1. Consequently, PSCA provides a diagnostic, prognostic, propylactic and/or therapeutic target for cancer. The PSCA gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with PSCA can be used in active or passive immunization.
Patent AU-2008265898-B2 (AU)
Title: Androstane and pregnane steroids with potent allosteric GABA receptor chloride ionophore modulating properties
Inventor: RUNYON SCOTT P
IPC: A61P25/02
Filed: 2008-06-16
Granted: 2013-11-28
Abstract: This invention describes compounds of Structures 1, 2, and 3 and their use as allosteric modulators of the GABA receptor chloride ionophore complex to alleviate stress, anxiety, mood disorders, seizures, depression, treatment of drug and alcohol abuse, memory, premenstrual disorders, and neural system damage.
Patent AU-2008266189-B2 (AU)
Title: Microwave integrated circuit package and method for forming such package
Inventor: COLOMB FRANCOIS Y
IPC: H01L23/66
Filed: 2008-06-12
Granted: 2013-09-19
Abstract: A method for packaging a semiconductor device. The method includes: providing a dielectric layer over the semiconductor device; determining patterns and placement of material on the dielectric layer to provide a predetermined magnetic or electric effect for the device, such effects being provided on the device from such patterned and placed material solely by electrical or magnetic waves coupled between such material and the device; and forming the material in the determined patterns and placement to provide the predetermined effects.
Patent AU-2008274476-B2 (AU)
Title: Roller press with displaceable head elements
Inventor: HELMUT LUCKE
IPC: B30B3/02
Filed: 2008-06-16
Granted: 2011-11-17
Abstract: The invention relates to a roller press with two rollers (1, 2) mounted rotatably in a frame (3, 4, 5, 6). For fitting or removing the rollers, at least one head element (5, 6) of the frame can be moved out of its operating position by being displaced outwards in the transverse direction. Such a configuration is distinguished by low-cost production of the roller press and time-saving fitting and removal of the rollers.
Patent AU-2008288946-B2 (AU)
Title: Method and system for implementing a dynamic verification value
Inventor: GERBER GARY
IPC: G06Q20/00
Filed: 2008-08-20
Granted: 2013-10-03
Abstract: A method is disclosed, which includes receiving a message including an account identifier and a first verification value. The method uses the account identifier to select a dynamic verification value process from at least two dynamic verification value processes. Then, using the selected dynamic verification value process, a second verification value is determined. Next, the method determines if the first verification value and the second verification value match or are within an expected range.
Patent AU-2008328588-B2 (AU)
Title: Electrochemical detection of a metal - labelled analyte
Inventor: SZYMANSKI MATEUSZ
IPC: G01N33/543
Filed: 2008-11-25
Granted: 2013-09-05
Abstract: A method for determining the presence or amount of a metal-labelled analyte (12) in a sample is described. The method comprises the steps of adding a release agent (20) to the metal labelled analyte (12) to release the metal label (18) from the analyte (12), the release agent (20) forming a charged stable species (22) with the metal label (18), applying a potential to bring the charged stable species (22) to an electrode (22), dissolving the charged stable species (22) under a positive potential to form metal ions (26), and carrying out a quantitative determination procedure such as anodic stripping voltammetry to determine the presence or amount of the metal-labelled analyte (12).
Patent AU-2008332563-B2 (AU)
Title: Structure and method for mounting seat for vehicle
Inventor: SHINJI KURACHI
IPC: B60N2/90
Filed: 2008-09-26
Granted: 2011-07-14
Abstract: A structure (3) for mounting a seat for a vehicle on the floor surface of the vehicle comprises a rail (4) laid on the floor surface of the vehicle in the longitudinal direction, a molding (5) having through holes (51) at desired positions and so disposed as to cover the rail (4), and seat-fixing members (6) each having a bolt part (61) fastened to the seat and an engagement part (62) engaged with the rail (4). The seat-fixing members (6) are so disposed that the bolt parts (61) are so inserted through the through holes (51) of the molding (5) as to project upward. The arrangement positions of the seat fixing parts are determined by the positions of the through holes (51) of the molding (5).
Patent AU-2008360658-B2 (AU)
Title: S0X9, prostaglandin D2 and retinoic acid for treating pigmentary conditions and melanoma
Inventor: HEARING VINCENT J
IPC: C07K14/47
Filed: 2008-08-15
Granted: 2015-02-19
Abstract: A method of treating a hypopigmentary condition in a subject comprising administering to the subject an amount of SOX9 sufficient to treat melanoma is disclosed. The hypopigmentary condition can be a result of surgery, trauma or vitiligo. A method of treating a hyperpigmentary condition in a subject comprising administering to the subject an amount of inhibitor of SOX9 activity sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising administering to the subject an amount of SOX9 sufficient to treat melanoma is disclosed. A method of treating melanoma in a subject comprising increasing the amounts of retinoic acid and SOX9 in the subject by amounts sufficient to treat melanoma. A method of treating melanoma in a subject comprising administering to the subject an amount of prostaglandin D2 (PGD2) and retinoic acid (RA) sufficient to treat cancer. A method of sensitizing a melanoma cell to RA comprising administering to the subject an amount of SOX9 sufficient to decrease PRAME expression. A method of increasing p21 expression in a subject comprising administering to the subject an amount of SOX9 sufficient to increase p21 expression. Methods of screening for compounds that treat hypopigmentary conditions and/or melanoma are provided.
Patent AU-2009212925-B2 (AU)
Title: Hood restraint device
Inventor: CRITCHLEY DAVID J
IPC: B62D25/12
Filed: 2009-09-03
Granted: 2015-03-26
Abstract: A restraint device includes a latch and a catch. The latch is rotatable between a first latch position and a 5 second latch position about a latch axis of rotation, which is remote from the latch. The catch is provided with a first arm and a second arm. The catch is rotatable about a catch axis of rotation between a first catch position and a second catch position. The catch axis of rotation extends through 10 the catch. When the catch is in the first catch position, the latch, as it is rotated from the first latch position toward the second latch position, contacts the first arm to rotate the catch about the catch axis of rotation, thereby allowing the latch to rotate about the latch axis of 15 rotation past the catch. When the catch is in the first catch position, the latch, as it is rotated from the second latch position toward the first latch position, contacts the first arm, which thereby engages the latch and restrains further rotation of the latch about the latch axis of 20 rotation toward the first latch position. When the catch is in the second catch position, the latch, as it is rotated from the second latch position toward the first latch position, contacts the second arm to rotate the catch about the catch axis of rotation, whereby the catch transitions 25 from the second position to the first position as the latch rotates about the latch axis of rotation past the catch and toward the first latch position. 1752170_2 (GHWattrs) 40,
Patent AU-2009215934-B2 (AU)
Title: Mesenchymal stem cell particles
Inventor: LIM SAI KIANG
IPC: A61K35/28
Filed: 2009-02-21
Granted: 2013-10-24
Abstract: We describe a particle secreted by a mesenchymal stem cell and comprising at least one biological property of a mesenchymal stem cell. The biological property may comprise a biological activity of a mesenchymal stem cell conditioned medium (MSC- CM) such as cardioprotection or reduction of infarct size. The particle may comprise a vesicle or an exosome.
Patent AU-2009225583-B2 (AU)
Title: A system and method for enhanced removal of CO2 from a mixed gas stream via use of a catalyst
Inventor: HANDAGAMA NARESHKUMAR B
IPC: B01D53/96
Filed: 2009-03-19
Granted: 2013-01-31
Abstract: The proposed invention is directed to a solvent based flue gas processing system for removing CO2 from a flue gas stream. A catalyst is provided to increase the efficiency of the solvent in capturing CO2 from the flue gas stream or in regenerating the solvent.
Patent AU-2009230096-B2 (AU)
Title: Salty taste enhancer and food or drink containing same
Inventor: SUGIYAMA KIMINORI
IPC: A23L27/21
Filed: 2009-03-23
Granted: 2014-01-23
Abstract: Provided is an excellent salty taste enhancing agent capable of compensating for low salty taste when aiming at reduction of salt. The salty taste enhancing agent comprises a mixture of an enzymatic degradation product of an animal protein and an enzymatic degradation product of a vegetable protein. The enzymatic degradation product is obtained by a protein hydrolase and/or nucleic acid hydrolase. The animal protein is a fish or shellfish extract and the vegetable protein is a soybean protein. The salty taste enhancing agent further comprises a basic amino acid, particularly arginine. The salty taste enhancing agent further comprises potassium chloride. The salty taste enhancing agent is adjusted to weak acidity. Further provided are a method of producing the same, a method of enhancing salty taste using the same, and a food or drink comprising the same.
Patent AU-2009238370-B2 (AU)
Title: Alpha 2B or 2B/2C adrenoceptor agonists for the treatment of neurodegeneration
Inventor: WHEELER LARRY A
IPC: A61P25/28
Filed: 2009-11-20
Granted: 2011-07-21
Abstract: C NRPorb\CC\CRN\261062_I DOC-2/12/209 ALPHA 2B OR 2B/2C ADRENOCEPTOR AGONISTS FOR THE TREATMENT OF NEURODEGENERATION Methods of preventing or retarding the degeneration of neurons. Also disclosed are methods for treating Alzheimer's disease or Parkinson's disease through the administration of selective alpha 2B or alpha 2B/2C receptor agonists, hereby incorporated by reference herein.
Patent AU-2009239649-B2 (AU)
Title: Diffractive lens exhibiting enhanced optical performance
Inventor: WEEBER HENDRIK A
IPC: G02C7/04
Filed: 2009-04-23
Granted: 2014-11-13
Abstract: The present invention provides improved ophthalmic lenses and methods for their design and use. Monofocal and multifocal diffractive ophthalmic lenses having reduced light scatter, improved light energy distribution properties, and/or other improvements in optical performance are provided. These properties are provided, at least in part, by the diffractive profiles of the invention, often having subtlety shaped echelettes with appropriately curving profiles. Smooth diffractive profiles may be used reduce light scatter. Diffractive profiles may be configured to limit the light energy in certain selected orders, thereby improving viewing quality and mitigating unwanted effects such as dysphotopsia. Diffractive profiles of may additionally or alternatively vary the light energy distributed between individual echelettes, providing additional advantages in various viewing situations.
Patent AU-2009248439-B2 (AU)
Title: Method of operating a home automation system
Inventor: DUCHENE ISABELLE
IPC: G05B19/042
Filed: 2009-12-10
Granted: 2016-02-11
Abstract: Abstract Method of operating a home automation system comprising: 5 - at least one home automation equipment item of a building, the home automation equipment item being associated with a specific equipment control means, - a device for controlling this home automation equipment item, comprising a display and control screen on which a portion of 10 the screen is assigned to the display of a first graphic representation, associated with this equipment item, the control device being separate from the specific control means, characterized in that it comprises a step for setting at least one value of a parameter of the home automation equipment item involved in the 15 definition of a scenario, this setting step being able to be both implemented by action on the specific control means so as to cause a phase for modification of the state of the home automation equipment item and by action on the control device so as to cause a phase for modification of the appearance of the first graphic representation of the 20 home automation equipment item. 1 Ala Fig. 1 I' 2 0a JII 2 0b 202a 100 3001P 2 210w Loci 4a 4 23 F--------------------- * 51 52 :L0C P 3b 30bP
Patent AU-2009251914-B2 (AU)
Title: A road rail
Inventor: WELANDSON ANDERS
IPC: E01F15/04
Filed: 2009-05-20
Granted: 2014-11-27
Abstract: A road rail comprises tubular posts (1; 20) to be anchored in the ground and a rail profile (2; 21) to be attached to the posts. The rail profile has a substantially closed cross-section but is open downwards for lowering onto the posts. The rail profile is supported on each post by a support member (5; 24) carried by lower edges of opposed cutouts (4; 23) in the post. At least one locking member (7; 26) inside the rail profile provides locking between the post and the rail profile by engagement on one hand with the rail profile and on the other hand with an upper edge of each post cutout (4; 23) by a locking tongue (10; 27) of the locking member.
Patent AU-2009253842-B2 (AU)
Title: Method and composition for sealing passages
Inventor: GROBLER NICO JOHAN
IPC: C08L7/02
Filed: 2009-06-03
Granted: 2012-05-24
Abstract: A method of sealing a passage in a body with a sealing composition comprising (a) a major proportion of a latex emulsion or colloid; and (b) a minor proportion of lauric acid or a laurate compound; and (c) at least one further selected additive, ideally a latex coagulation inhibitor, wherein said composition is pumped into said passage where it is set or coagulated to form a seal. Advantageously, the laurate compound is ammonium laurate and coagulation is conveniently induced by adjusting pH of the sealing composition from alkaline to acidic pH range. The method is particularly well suited to sealing in faulty formations or sealing sites and may be used in sealing within salt mines which contain brines.
Patent AU-2009256609-B2 (AU)
Title: Composition and process for whitening paper
Inventor: TAUBER ANDREI
IPC: C07D251/00
Filed: 2009-06-10
Granted: 2013-08-22
Abstract: The invention relates to a composition suitable for surface treatment of paper, wherein the composition contains a specified fluorescent whitening agent with alkylsulfonic acid groups, a salt of a bivalent cation, and a carrier. The composition is used for whitening paper, in particular in the size press.
Patent AU-2009274129-B2 (AU)
Title: Structural variants of antibodies for improved therapeutic characteristics
Inventor: GOLDENBERG DAVID M
IPC: A61K39/395
Filed: 2009-07-21
Granted: 2016-02-25
Abstract: The present invention provides substituted humanized, chimeric or human anti-CD20 antibodies or antigen binding fragments thereof and bispecific antibodies or fusion proteins comprising the substituted antibodies or antigen binding fragments thereof. The antibodies, fusion proteins or fragments are useful for treatment of B-cell disorders, such as B-cell malignancies and autoimmune diseases, as well as GVHD, organ transplant rejection, and hemolytic anemia and cryoglobulinemia. Amino acid substitutions, particularly substitution of an aspartate residue at Kabat position 101 of CDR3 V
Patent AU-2009294374-B2 (AU)
Title: Subsea apparatus
Inventor: EDWARDS JEFFREY CHARLES
IPC: E21B23/04
Filed: 2009-09-16
Granted: 2015-04-02
Abstract: An apparatus (10) for remotely running a subsea production tree (12) and desuspending a well is described. The apparatus comprises a tree running tool (16) adapted to be connected to a production tree, at least one downhole tool, at least one of the tools being a plug retrieval tool (22) and a tool deployment device (18) in hydraulic communication with at least the plug retrieval tool to hydraulically operate the plug retrieval tool.
Patent AU-2009309336-B2 (AU)
Title: Ubiquitin specific proteases responsible for Mcl-1 stability and uses thereof
Inventor: GENESTE OLIVIER
IPC: C12Q1/37
Filed: 2009-10-29
Granted: 2012-08-30
Abstract: Use of a polypeptide selected from the group consisting of USP13, USP26, USP38, USP42 or USP46 as a screening tool for an agent for treating cancer.
Patent AU-2009310951-B2 (AU)
Title: Method and of apparatus for manufacturing a bent product
Inventor: TOMIZAWA ATSUSHI
IPC: B21D7/16
Filed: 2009-10-27
Granted: 2013-09-05
Abstract: A method of manufacturing a bent product, wherein, even if the product must be provided with bends with various shapes or the product must be formed by bending a metal material having high strength, the method can perform such bending with high working accuracy and can obtain a large bend angle without impairing the surface properties of the metal material. A steel pipe (1) is supported at a first position (A) while being fed in the longitudinal direction of the steel pipe (1), the steel pipe (1) being fed is partially heated at a second position (B), and the heated portion of the steel pipe (1) is cooled at a third position (C).  Then, the position of a clamping means (15) for clamping the steel pipe (1) in a region (D) located downstream of the third position (C) is changed, in a work space including an empty space located on the upstream of the third position (C) in the feeding direction of the steel pipe (1), to a three-dimensional direction including the feeding direction of the steel pipe (1).  Thus, bending moment is applied to the heated portion of the steel pipe (1) to produce the bent product having three-dimensionally bent portions provided intermittently or continuously to the steel pipe (1) in the longitudinal direction thereof.
Patent AU-2009313638-B2 (AU)
Title: Method and apparatus for rotationally restraining a mixing container
Inventor: FARRELL JAMES J
IPC: B65D1/40
Filed: 2009-11-03
Granted: 2015-12-03
Abstract: A container for containing food and/or beverage ingredients is described. The container is of a type which may be supported in a support while the ingredients inside the container are processed, such as by a rotating blade or other mechanism. The container includes anti-rotation elements positionable in anti-rotational contact with a corresponding protruding portion in a container support in a manner which restricts rotational movement of the vessel relative to the container support. The off-set between each of the anti-rotation elements is an angle other than 180°.
Patent AU-2009323734-B2 (AU)
Title: Modified protozoan expressing at least two variable surface proteins (VSP), a vaccine comprising it and procedures, uses, and methods thereof
Inventor: LUJAN HUGO DANIEL
IPC: A61K39/002
Filed: 2009-12-02
Granted: 2016-06-30
Abstract: Modified protozoa parasites comprising simultaneous expression on its surface of at least two variable surface proteins (VSP). The modified protozoa may also simultaneously express the complete repertoire of variable surface proteins. Protozoa show reduced expression of Dicer, RNA-dependant RNA-polymerase (RdRP) enzymes or both, wherein the RdRP gene and/or the Dicer gene has been silenced. The protozoan may be any protozoan showing an antigenic variation mechanism.
Patent AU-2009334689-B2 (AU)
Title: Method for preparing activated esters
Inventor: BIGOT ANTONY
IPC: C07D401/12
Filed: 2009-12-15
Granted: 2015-10-08
Abstract: The invention relates to a method for preparing an activated ester of the formula (I), where R is a (C
Patent AU-2009336107-B2 (AU)
Title: Expandable face mask with engageable stiffening element
Inventor: DUFFY DEAN R
IPC: A62B9/00
Filed: 2009-11-24
Granted: 2011-11-10
Abstract: Herein are disclosed face masks that are provided in a generally flat configuration and are capable of being expanded to a cup-shaped configuration. Such masks comprise at least one porous layer that comprises at least one pleat and that is capable of being expanded by at least partially unfolding the at least one pleat. The mask further comprises at least one stiffening element that comprises at least one engaging feature. Upon expanding the porous layer, the engaging feature engages with the porous layer so as to enhance the ability of the mask to maintain the expanded, cup-shaped configuration.